Health Canada approves Moderna XBB.1.5 COVID vaccine

OTTAWA, Sept. 12 (Xinhua) -- Health Canada said Tuesday it has authorized the use of the Moderna SPIKEVAX COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older.

According to a statement issued by the national health regulator, individuals five years of age and older should receive one dose, regardless of their COVID-19 vaccination history. Children between six months and four years of age should receive two doses if they have not been previously vaccinated with a COVID-19 vaccine, or one dose if they have been previously vaccinated with one or more doses of a COVID-19 vaccine.